Hydroxyurea gets DCGI approval for treatment of sickle cell anaemia
Hyderabad: The Drugs Controller General of India (DCGI) has approved hydroxyurea for treatment of Sickle Cell Anaemia.
The CSIR-Sickle Cell Anaemia (CSIR-SCA) Mission, coordinated by the CSIR-Centre for Cellular and Molecular Biology…